Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Esperion
Pharma
Esperion to go private in potential $1.1B buyout by ArchiMed
After a March M&A move of its own, Esperion Therapeutics is itself being acquired and taken private by healthcare investment firm ArchiMed.
Fraiser Kansteiner
May 1, 2026 11:26am
Esperion pays $75M for Corstasis and FDA-approved nasal spray
Mar 3, 2026 8:40am
Sun, Eisai, AstraZeneca—Fierce Pharma Asia
Mar 17, 2023 8:00am
Daiichi hesitant to fork over milestones to Esperion: filing
Mar 16, 2023 3:30pm
Cholesterol drug developer cuts 40% of workforce
Oct 18, 2021 12:00pm
#FierceMadness: Roche, Novartis, AbbVie, Biohaven brands advance
Mar 17, 2021 9:00am
